Advertisement
Canada markets close in 3 hours 48 minutes
  • S&P/TSX

    22,141.20
    -582.01 (-2.56%)
     
  • S&P 500

    5,328.57
    -118.11 (-2.17%)
     
  • DOW

    39,530.22
    -817.75 (-2.03%)
     
  • CAD/USD

    0.7219
    +0.0008 (+0.12%)
     
  • CRUDE OIL

    73.83
    -2.48 (-3.25%)
     
  • Bitcoin CAD

    87,602.60
    +426.73 (+0.49%)
     
  • CMC Crypto 200

    1,308.28
    -13.49 (-1.02%)
     
  • GOLD FUTURES

    2,475.80
    -5.00 (-0.20%)
     
  • RUSSELL 2000

    2,105.17
    -80.99 (-3.70%)
     
  • 10-Yr Bond

    3.8190
    -0.1570 (-3.95%)
     
  • NASDAQ

    16,751.69
    -442.46 (-2.57%)
     
  • VOLATILITY

    26.38
    +7.79 (+41.72%)
     
  • FTSE

    8,174.71
    -108.65 (-1.31%)
     
  • NIKKEI 225

    35,909.70
    -2,216.63 (-5.81%)
     
  • CAD/EUR

    0.6618
    -0.0060 (-0.90%)
     

Austco Healthcare's (ASX:AHC) 24% CAGR outpaced the company's earnings growth over the same five-year period

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. One great example is Austco Healthcare Limited (ASX:AHC) which saw its share price drive 175% higher over five years. And in the last week the share price has popped 22%.

Since the stock has added AU$14m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

Check out our latest analysis for Austco Healthcare

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

ADVERTISEMENT

During five years of share price growth, Austco Healthcare achieved compound earnings per share (EPS) growth of 35% per year. This EPS growth is higher than the 22% average annual increase in the share price. So it seems the market isn't so enthusiastic about the stock these days.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

earnings-per-share-growth
earnings-per-share-growth

It's good to see that there was some significant insider buying in the last three months. That's a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. This free interactive report on Austco Healthcare's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

What About The Total Shareholder Return (TSR)?

We'd be remiss not to mention the difference between Austco Healthcare's total shareholder return (TSR) and its share price return. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Austco Healthcare's TSR of 187% for the 5 years exceeded its share price return, because it has paid dividends.

A Different Perspective

We're pleased to report that Austco Healthcare shareholders have received a total shareholder return of 30% over one year. That's better than the annualised return of 24% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Austco Healthcare that you should be aware of before investing here.

Austco Healthcare is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com